Showing results (251-260 of 287) with videos related to
Sort By:
Pageof 29
The American Journal of Gastroenterology|June 25, 2025
A Prospective Comparison of Ustekinumab and Antitumor Necrosis Factor α Therapy in the Treatment of Crohn's-Like Disease of the PouchEdward L Barnes, Laura Raffals, Taha Qazi, et al.Gastrointestinal Endoscopy|December 21, 2014
The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placementNeel S Choksi, Evan L Fogel, Gregory A Cote, et al.Gut|February 18, 2017
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trialsJulian Panés, William J Sandborn, Stefan Schreiber, et al.Journal of Crohn'S & Colitis|February 5, 2019
CD4+ Tissue-resident Memory T Cells Expand and Are a Major Source of Mucosal Tumour Necrosis Factor α in Active Crohn's DiseaseShrinivas Bishu, Mohammed El Zaatari, Atsushi Hayashi, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 16, 2025
Postoperative Outcomes in Tofacitinib-Treated Patients With Acute Severe Ulcerative Colitis Undergoing ColectomyCharlotte Larson, Jeffrey A Berinstein, Nicholas Tedesco, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 5, 2021
Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn's Disease: A Systematic ReviewCalen A Steiner, Jeffrey A Berinstein, Jeremy Louissaint, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 12, 2020
Coronavirus Disease 2019 (COVID-19) Clinical Trial Oversight at a Major Academic Medical Center: Approach of Michigan MedicineKayte Spector-Bagdady, Peter D R Higgins, Keith D Aaronson, et al.The Lancet. Gastroenterology & Hepatology|September 8, 2023
Efficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHIEVE Maintenance): overall results from the randomised, placebo-controlled, double-blind, phase 3 maintenance studySéverine Vermeire, Silvio Danese, Wen Zhou, et al.Gastroenterology|November 8, 2021
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn's DiseaseBruce E Sands, Laurent Peyrin-Biroulet, Jaroslaw Kierkus, et al.The American Journal of Pathology|February 15, 2015
Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosisThomas H Sisson, Iyabode O Ajayi, Natalya Subbotina, et al.Pageof 29